Stay updated on Psilocybin for MDD: Novel Clinical Trial
Sign up to get notified when there's something new on the Psilocybin for MDD: Novel Clinical Trial page.

Latest updates to the Psilocybin for MDD: Novel Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRevision: v3.3.4 is now displayed, replacing v3.3.3. There are no changes to the study details on the page.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedThe Locations section was expanded to include participating sites across multiple states under a consolidated listing, and older per-state subsections were removed with the revision updated to 3.3.3.SummaryDifference1%

- Check59 days agoChange DetectedEditorial notes were added to explain PubMed-derived publications and a revision label was updated; these changes do not modify the study's design, endpoints, eligibility criteria, or other core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check66 days agoChange DetectedThe funding-status banner related to government operations was removed, and there are no changes to the study details or page navigation.SummaryDifference0.3%

- Check81 days agoChange DetectedNo significant content changes detected on the Study Details page for NCT03866174; the updates seem to be formatting and layout tweaks without edits to core study information like locations, criteria, dates, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check109 days agoChange DetectedAdded a government funding notice and a new v3.2.0 revision; removed the old v3.1.0 revision.SummaryDifference2%

Stay in the know with updates to Psilocybin for MDD: Novel Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Psilocybin for MDD: Novel Clinical Trial page.